| INTRODUCTION
Familial Mediterranean fever (FMF, OMIM 249100) is an autosomal recessive inherited, autoinflammatory disease. 1 The major clinical manifestations of FMF are self-limited attacks of acute fever accompanied by abdominal pain, arthritis, polyserositis including peritonitis, pleuritis and synovitis 1. FMF frequently affects Mediterranean populations including Jews, Armenians, Turks, and Arabs. MEFV gene, the gene associated with FMF, encodes a protein of 781 amino acids termed pyrin or marenostrin, which is primarily expressed in mature granulocytes. Pyrin has been shown to be a component of inflammasome complex (particularly the NLRP3 inflammasome), an intracellular organelle, which is implied for the production of interleukin-1β. 2 Acute FMF attacks are manifested by a nonspecific elevation in inflammatory mediators, including serum amyloid A (SAA), fibrinogen, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). 3, 4 However, a significant subclinical inflammation can be also seen during the interval between attacks. 3 The Methylenetetrahydrofolate reductase (MTHFR) enzyme, encoded by MTHFR gene, irreversibly converts 5,10-methylenetetrahydrofolate (5,10-MTHF) to 5-methyltetrahydrofolate (5-MTHF). 5 This reaction is essential for the sequential biochemical mechanism that transforms the amino acid homocysteine (Hcy) to amino acid methionine. 6 The human MTHFR gene is composed of 11 exons and 10 introns and located on the short arm of chromosome 1 (1p36.3). 7 MTHFR gene have two common allelic variants, C677T (rs1801133) and A1298C (rs1801131), which lead to the amino acid substitutions Ala222Val and Glu429Ala, respectively. 8 The C to T change at nucleotide 677 leads to a more thermolabile MTHFR, decreases its enzyme activity, and is related with higher plasma homocysteine levels. 9 Similarly, the A1298C variant may also have an impact on MTHFR activity and plasma Hcy values.
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Several in vitro studies reported that Hcy was associated with a proinflammatory response in animal models and in humans. 11 Therefore, we aimed to examine the possible association between MTHFR C677T and A1298C variants and FMF susceptibility in Turkish population. 
| MATERIALS AND METHODS

| Patients
| Genotyping
Genomic DNA was extracted from EDTA anticoagulated peripheral blood leukocytes using a commercial DNA isolation kit (Sigma-Aldrich, Taufkirchen, Germany). The C677T and A1298C variants in MTHFR gene were determined by polymerase chain reaction (PCR) followed by restriction fragment length polymorphisms (RFLP). 7 The MTHFR Second PCR was performed to confirm samples whose results were not clear.
| Statistical analysis
All statistical analyses were performed using computer SPSS 
| RESULTS
A total number of 298 subjects from a Turkish population were recruited (100 controls, 198 patients with FMF) in this study. In the study group, there were 87 males (43.9%) and 111 (56.1%) females.
There were 42 (42%) male controls and 58 (58%) female controls. The demographical characteristics of the two groups and clinical characteristics of patients are presented in Table 1 . Age of first symptoms, age of diagnosis, the frequency of attacks, colchicine use, family history, fever, abdominal pain, thoracic pain, joint involvement, appendicitis, amyloidosis, and erythema were analyzed. Table 2 shows the genotype distribution and allele frequency of the MTHFR C677T and A1298C variants in FMF patients and controls.
The frequency of the CC, CT, and TT genotypes of the MTHFR C677T variant in the patients was 48%, 42.4%, and 9.6% respectively, and in the controls the frequency was 66%, 31%, and 3%, respectively. The genotype distribution of the MTHFR C677T variant was statistically different between the FMF patients and the control group (P=.006).
There was a significant difference for allele frequency of the MTHFR C677T. MTHFR C677T TT genotype and T allele were more prevalent in patient group. High differences were also observed when the patients and the controls were compared according to CC vs CT+TT (Table 2) .
We also examined the risk associated with inheriting the combined genotypes for the two MTHFR variants (Table 3 ). According to these results, individuals who were CC homozygous at C677T locus and AA homozygous at A1298C locus have a lower risk of developing FMF (P=.002). Also, individuals who were TT homozygous at C677T locus and AC heterozygous at A1298C locus have higher risk of developing FMF (P=.033).
| DISCUSSION
FMF is a systemic autoinflammatory disorder characterized by ostensibly unprovoked activation of distinct inflammatory pathways.
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Although FMF is a single gene disease, the real etiopathogenesis of FMF is not well understood. An abnormal form of pyrin which is encoded by the MEFV gene results in inflammation in FMF. These inflammatory attacks are then manifested by an intense accumulation of neutrophils into the serous cavities and are associated with an increase in the levels of acute-phase proteins and cytokines. 2 Most of the patients experience symptom-free intervals which are characterized by subclinical inflammation with excess production of SAA, an acute phase reactant synthesized in response to pro-inflammatory cytokines; this finding may be considered as a marker of subclinical systemic inflammation. 4 Hcy, an endogenous sulfur-containing amino acid, is produced by the methionine metabolism. Hcy has a potent oxidant effect and its oxidation end-products are toxic. 15 Hyperhomocysteinaemia (HCA), the accumulation of homocystein in the circulation, is acts as an independent risk factor for atherosclerotic vascular disease by inducing platelet activation, promoting smooth muscle cell proliferation, displaying cytotoxicity, leading to endothelial dysfunction, and stimulating the low-density lipoprotein (LDL) oxidation. 16 It is reported that HCA was associated with enhanced carotid artery permeability, which could affect LDL intravasation and accumulation in the arterial wall in rats. 17 Rohde et al. reported that HCA is associated with an elevation of CRP, acute phase reactant. 18 Recently it has been shown that inflammation induces every aspect of atherosclerotic process. Chronic HCA and inflammatory cytokines could contribute to the occurrence of endothelial dysfunction.
Disorders with ongoing subclinical inflammation, such as systemic lupus erythematosus, rheumatoid arthritis, and diabetes mellitus, are believed to have an increased risk of early structural vascular change and atherosclerosis. 19, 20 Due to nature of the disease, patients with FMF should be considered to face an increased risk of early vascular change and atherosclerosis. Basar et al. reported that MEFV gene mutations had significantly increased in patients with young coronary heart disease. 21 Also, it was shown that atherogenic index values were significantly higher in patients with FMF than control group. 22 Besides, studies demonstrated that common carotide artery intima-media thickness, a non-invasive predictor of early arterial wall alteration, increased in FMF patients. 23, 24 MTHFR C677T variant in the catalytic domain of the protein, the binding site for the MTHFR co-factor flavin adenine dinucleotide, is associated with increased thermolability of the enzyme, reduction in the activity and elevated plasma Hcy concentrations, along with lowered plasma folate. 7 Homozygous TT have about 30% of The frequency of attacks, mean±SD (day) normal enzyme activity, while heterozygous CT have approximately 60% of the normal enzyme activity, therefore they incline to collect 5,10-methylene-THF displacing the reaction toward the DNA production despite diminishing the pool of methyl donors. 25 
MTHFR
A1298T variant is located in the C-terminal end of the enzyme, the S-adenosymethionine-regulatory domain, and may lead to a reduction in 40% in enzyme activity of the variant genotype. 26 The prevalence of the two variants differs in certain geographical regions and ethnic groups. 27 Several studies have been performed to evaluate the effects of MTHFR C677T and A1298T variants on the risk of different conditions including cancer, 28 congenital heart disease, 29 leukemia, 30 recurrent pregnancy loss, 31 obesity, 32 and hypertension. 33 In this study, we aimed to investigate possible association of the C677T and A1298C variants in the MTHFR gene and susceptibility to FMF in a cohort of Turkish patients. To the best of our knowledge, this is the first study to elucidate the potential association MTHFR variants with FMF risk in Turkish patients. The genotype distribution and allele frequency of the MTHFR C677T variant showed statistically significant difference between the patients and the controls (P=.006
and P=.001, respectively; Table 2 ). We found that MTHFR C677T TT genotype and T allele were higher in patients group. In vivo and in vitro studies reported that individuals homozygous for the T allele have significantly higher Hcy levels. 7 Also previously, Karatay et al.
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reported that serum Hcy levels are often increased in FMF patients during attack-free periods. Our results were consistent with both data.
Furthermore, they would help to explain the atherosclerosis in FMF.
In addition, a significant association was observed when the patients were compared with the controls according to CC genotype vs CT+TT genotypes and TT genotype vs CC+CT genotype.
Although genotype distribution of MTHFR A1298C variant did not
show statistically significant differences between patients and controls Table 2 ).
C allele was significantly higher in the patients group than the control group. It was previously reported that the C allele of A1298C variant generates a reduction in MTHFR enzyme activity, 35 and can also lead to an elevation of plasma Hcy. 36 These data were also consistent with MTHFR C677T variant results.
In addition, we evaluated genotype combinations for the two MTHFR loci. For the two genotype combinations, two of them were found to be significantly different FMF patients and control subjects.
The CC-AA genotype was found to be significantly decreased in the FMF patients, while the TT-AC genotype was found to be significantly more frequent in the control subjects (P=.02, P=.033, respectively) ( Table 3 ).
In conclusion, we report the first association to our knowledge between MTHFR gene variants and FMF in Turkish population. The present study revealed that MTHFR C677T and A1298C variants are strongly associated with a susceptibility to FMF. Our results suggest that the MTHFR C677T and A1298C variants may be a useful tool to predict the susceptibility of FMF and its complications. Further investigations with larger populations are needed to confirm the association between MTHFR gene variants and FMF. We believe that with the help of newly designed studies, the association first emphasized here will better elucidate this interaction and clarify the pathogenesis of FMF.
